FORTACIN 150 mg/ml / 50 mg/ml, spray cutaneous,solution bottle, 5 ml
Active ingredients: Lidocaine, Prilocaine
Commercialized according to BDPM
Solution for sprayingbottle, 5 mlcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FORTACIN 150 mg/ml / 50 mg/ml, spray cutané,solution
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- cutanée
- Presentation description
- 1 flacon(s) pulvérisateur(s) aluminium de 5 ml
- Marketing authorisation holder
- RECORDATI IRELAND
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Feb 2018
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67099299CIP73007365CIP133400930073650Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNEsolution | 150 mg · 1 ml de solution | SA |
| PRILOCAÏNEsolution | 50 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.